Legal Tetrahydrocannabinol in the US—Regulatory Loopholes
This Viewpoint identifies regulatory loopholes in the legal manufacture and sale of nonmedical products with intoxicating tetrahydrocannabinol levels in the US, and it calls for increased congressional oversight and research funding to address these regulatory gaps.
Authors
- Jennifer Pearson (ORCID: https://orcid.org/0000-0002-1400-5932)
- Abigail S. Friedman (ORCID: https://orcid.org/0000-0002-2352-8786)
- Grant C. Nippler
Institutions
- University of Nevada, Reno (US)
- Renown Health (US)
- Yale New Haven Health System (US)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2026-05-29
- DOI
- https://doi.org/10.1001/jamahealthforum.2026.1385
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00